Abstract | INTRODUCTION: METHODS: Muscle-specific transgenic expression and postnatal viral delivery of Igf1 were used in Dysf-/- and control mice. Increased IGF-1 levels were confirmed by enzyme-linked immunosorbent assay. Testing for skeletal muscle mass and function was performed in male and female mice. RESULTS: Muscle hypertrophy occurred in response to increased IGF-1 in mice with and without dysferlin. Male mice showed a more robust response compared with females. Increased IGF-1 did not cause loss of force per cross-sectional area in Dysf-/- muscles. DISCUSSION: We conclude that increased local IGF-1 promotes functional hypertrophy when dysferlin is absent and reestablishes IGF-1 as a potential therapeutic for dysferlinopathies.
|
Authors | Elisabeth R Barton, Jennifer Pham, Becky K Brisson, SooHyun Park, Lucas R Smith, Min Liu, Zuozhen Tian, David W Hammers, Georgios Vassilakos, H Lee Sweeney |
Journal | Muscle & nerve
(Muscle Nerve)
Vol. 60
Issue 4
Pg. 464-473
(10 2019)
ISSN: 1097-4598 [Electronic] United States |
PMID | 31323135
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | © 2019 The Authors. Muscle & Nerve published by Wiley Periodicals, Inc. |
Chemical References |
- Dysf protein, mouse
- Dysferlin
- insulin-like growth factor-1, mouse
- Insulin-Like Growth Factor I
|
Topics |
- Animals
- Diaphragm
(metabolism, pathology)
- Dysferlin
(genetics)
- Insulin-Like Growth Factor I
(genetics)
- Mice
- Mice, Knockout
- Mice, Transgenic
- Muscle, Skeletal
(metabolism, pathology)
- Muscular Dystrophies
(genetics)
- Organ Size
|